Literature DB >> 20534860

Determinants in 3Dpol modulate the rate of growth of hepatitis A virus.

Krishnamurthy Konduru1, Gerardo G Kaplan.   

Abstract

Hepatitis A virus (HAV), an atypical member of the Picornaviridae, grows poorly in cell culture. To define determinants of HAV growth, we introduced a blasticidin (Bsd) resistance gene into the virus genome and selected variants that grew at high concentrations of Bsd. The mutants grew fast and had increased rates of RNA replication and translation but did not produce significantly higher virus yields. Nucleotide sequence analysis and reverse genetic studies revealed that a T6069G change resulting in a F42L amino acid substitution in the viral polymerase (3D(pol)) was required for growth at high Bsd concentrations whereas a silent C7027T mutation enhanced the growth rate. Here, we identified a novel determinant(s) in 3D(pol) that controls the kinetics of HAV growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534860      PMCID: PMC2916523          DOI: 10.1128/JVI.01470-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase.

Authors:  Jamie J Arnold; Marco Vignuzzi; Jeffrey K Stone; Raul Andino; Craig E Cameron
Journal:  J Biol Chem       Date:  2005-05-05       Impact factor: 5.157

2.  Rapid completion of the replication cycle of hepatitis A virus subsequent to reversal of guanidine inhibition.

Authors:  M W Cho; E Ehrenfeld
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

3.  Primary cleavage of the HAV capsid protein precursor in the middle of the proposed 2A coding region.

Authors:  X Y Jia; D F Summers; E Ehrenfeld
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

4.  Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus.

Authors:  J Graff; O C Richards; K M Swiderek; M T Davis; F Rusnak; S A Harmon; X Y Jia; D F Summers; E Ehrenfeld
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  Characterization of replication-competent hepatitis A virus constructs containing insertions at the N terminus of the polyprotein.

Authors:  Y Zhang; G G Kaplan
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Polyprotein processing in cis and in trans by hepatitis A virus 3C protease cloned and expressed in Escherichia coli.

Authors:  S A Harmon; W Updike; X Y Jia; D F Summers; E Ehrenfeld
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

7.  A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity.

Authors:  Julie K Pfeiffer; Karla Kirkegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

8.  Blasticidin S deaminase gene from Aspergillus terreus (BSD): a new drug resistance gene for transfection of mammalian cells.

Authors:  M Kimura; A Takatsuki; I Yamaguchi
Journal:  Biochim Biophys Acta       Date:  1994-11-22

9.  Kinetics of hepatitis A virus replication in vivo and in vitro using negative-strand quantitative PCR.

Authors:  V S de Paula; A S Perse; L A Amado; L M de Morais; S M B de Lima; R S Tourinho; A M C Gaspar; M A Pinto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-27       Impact factor: 3.267

10.  Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.

Authors:  A Martin; N Escriou; S F Chao; M Girard; S M Lemon; C Wychowski
Journal:  Virology       Date:  1995-10-20       Impact factor: 3.616

View more
  5 in total

1.  HAVCR1 (CD365) and Its Mouse Ortholog Are Functional Hepatitis A Virus (HAV) Cellular Receptors That Mediate HAV Infection.

Authors:  Maria Isabel Costafreda; Gerardo Kaplan
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

2.  Hepatitis A virus adaptation to cellular shutoff is driven by dynamic adjustments of codon usage and results in the selection of populations with altered capsids.

Authors:  M Isabel Costafreda; Francisco J Pérez-Rodriguez; Lucía D'Andrea; Susana Guix; Enric Ribes; Albert Bosch; Rosa M Pintó
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

Review 3.  Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus.

Authors:  Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Masato Nakamura; Xia Jiang; Yuki Haga; Reina Sasaki; Osamu Yokosuka
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

Review 4.  Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.

Authors:  Tatsuo Kanda; Reina Sasaki; Ryota Masuzaki; Naoki Matsumoto; Masahiro Ogawa; Mitsuhiko Moriyama
Journal:  Viruses       Date:  2020-05-12       Impact factor: 5.048

Review 5.  Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment.

Authors:  Marion Migueres; Sébastien Lhomme; Jacques Izopet
Journal:  Viruses       Date:  2021-09-22       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.